Literature DB >> 24025341

A combination HIV reporter virus system for measuring post-entry event efficiency and viral outcome in primary CD4+ T cell subsets.

Carisa A Tilton1, Caroline O Tabler, Mark B Lucera, Samantha L Marek, Aiman A Haqqani, John C Tilton.   

Abstract

Fusion between the viral membrane of human immunodeficiency virus (HIV) and the host cell marks the end of the HIV entry process and the beginning of a series of post-entry events including uncoating, reverse transcription, integration, and viral gene expression. The efficiency of post-entry events can be modulated by cellular factors including viral restriction factors and can lead to several distinct outcomes: productive, latent, or abortive infection. Understanding host and viral proteins impacting post-entry event efficiency and viral outcome is critical for strategies to reduce HIV infectivity and to optimize transduction of HIV-based gene therapy vectors. Here, we report a combination reporter virus system measuring both membrane fusion and viral promoter-driven gene expression. This system enables precise determination of unstimulated primary CD4+ T cell subsets targeted by HIV, the efficiency of post-entry viral events, and viral outcome and is compatible with high-throughput screening and cell-sorting methods.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Fusion; HIV; LTR; Outcome; Post-entry event efficiency; Reporter virus

Mesh:

Year:  2013        PMID: 24025341      PMCID: PMC3982591          DOI: 10.1016/j.jviromet.2013.08.029

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  27 in total

1.  Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding.

Authors:  U O'Doherty; W J Swiggard; M H Malim
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods.

Authors:  L Sastry; T Johnson; M J Hobson; B Smucker; K Cornetta
Journal:  Gene Ther       Date:  2002-09       Impact factor: 5.250

Review 3.  HIV reservoirs: pathogenesis and obstacles to viral eradication and cure.

Authors:  Tae-Wook Chun; Anthony S Fauci
Journal:  AIDS       Date:  2012-06-19       Impact factor: 4.177

4.  Phenotypic and immunologic comparison of clade B transmitted/founder and chronic HIV-1 envelope glycoproteins.

Authors:  Craig B Wilen; Nicholas F Parrish; Jennifer M Pfaff; Julie M Decker; Elizabeth A Henning; Hillel Haim; Josiah E Petersen; Jason A Wojcechowskyj; Joseph Sodroski; Barton F Haynes; David C Montefiori; John C Tilton; George M Shaw; Beatrice H Hahn; Robert W Doms
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

5.  Global landscape of HIV-human protein complexes.

Authors:  Stefanie Jäger; Peter Cimermancic; Natali Gulbahce; Jeffrey R Johnson; Kathryn E McGovern; Starlynn C Clarke; Michael Shales; Gaelle Mercenne; Lars Pache; Kathy Li; Hilda Hernandez; Gwendolyn M Jang; Shoshannah L Roth; Eyal Akiva; John Marlett; Melanie Stephens; Iván D'Orso; Jason Fernandes; Marie Fahey; Cathal Mahon; Anthony J O'Donoghue; Aleksandar Todorovic; John H Morris; David A Maltby; Tom Alber; Gerard Cagney; Frederic D Bushman; John A Young; Sumit K Chanda; Wesley I Sundquist; Tanja Kortemme; Ryan D Hernandez; Charles S Craik; Alma Burlingame; Andrej Sali; Alan D Frankel; Nevan J Krogan
Journal:  Nature       Date:  2011-12-21       Impact factor: 49.962

Review 6.  The molecular biology of HIV latency: breaking and restoring the Tat-dependent transcriptional circuit.

Authors:  Jonathan Karn
Journal:  Curr Opin HIV AIDS       Date:  2011-01       Impact factor: 4.283

Review 7.  HIV: cell binding and entry.

Authors:  Craig B Wilen; John C Tilton; Robert W Doms
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

8.  Tailored HIV-1 vectors for genetic modification of primary human dendritic cells and monocytes.

Authors:  Stéphanie Durand; Xuan-Nhi Nguyen; Jocelyn Turpin; Stephanie Cordeil; Nicolas Nazaret; Séverine Croze; Renaud Mahieux; Joël Lachuer; Catherine Legras-Lachuer; Andrea Cimarelli
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

9.  SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx.

Authors:  Nadine Laguette; Bijan Sobhian; Nicoletta Casartelli; Mathieu Ringeard; Christine Chable-Bessia; Emmanuel Ségéral; Ahmad Yatim; Stéphane Emiliani; Olivier Schwartz; Monsef Benkirane
Journal:  Nature       Date:  2011-05-25       Impact factor: 49.962

10.  Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein.

Authors:  Kasia Hrecka; Caili Hao; Magda Gierszewska; Selene K Swanson; Malgorzata Kesik-Brodacka; Smita Srivastava; Laurence Florens; Michael P Washburn; Jacek Skowronski
Journal:  Nature       Date:  2011-06-29       Impact factor: 49.962

View more
  10 in total

1.  Dendritic Cells Enhance HIV Infection of Memory CD4(+) T Cells in Human Lymphoid Tissues.

Authors:  Angel L Reyes-Rodriguez; Morgan A Reuter; David McDonald
Journal:  AIDS Res Hum Retroviruses       Date:  2016-01-07       Impact factor: 2.205

2.  Immune Control of HIV.

Authors:  Muthukumar Balasubramaniam; Jui Pandhare; Chandravanu Dash
Journal:  J Life Sci (Westlake Village)       Date:  2019-06

3.  High sensitivity detection and sorting of infectious human immunodeficiency virus (HIV-1) particles by flow virometry.

Authors:  Michał M Bonar; John C Tilton
Journal:  Virology       Date:  2017-02-21       Impact factor: 3.616

4.  The HIV-1 Viral Protease Is Activated during Assembly and Budding Prior to Particle Release.

Authors:  Caroline O Tabler; Sarah J Wegman; Jiji Chen; Hari Shroff; Najwa Alhusaini; John C Tilton
Journal:  J Virol       Date:  2022-04-19       Impact factor: 6.549

5.  CD4+ memory stem cells are infected by HIV-1 in a manner regulated in part by SAMHD1 expression.

Authors:  Caroline O Tabler; Mark B Lucera; Aiman A Haqqani; David J McDonald; Stephen A Migueles; Mark Connors; John C Tilton
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

6.  The histone deacetylase inhibitor vorinostat (SAHA) increases the susceptibility of uninfected CD4+ T cells to HIV by increasing the kinetics and efficiency of postentry viral events.

Authors:  Mark B Lucera; Carisa A Tilton; Hongxia Mao; Curtis Dobrowolski; Caroline O Tabler; Aiman A Haqqani; Jonathan Karn; John C Tilton
Journal:  J Virol       Date:  2014-07-09       Impact factor: 5.103

Review 7.  Stem memory T cells (TSCM)-their role in cancer and HIV immunotherapies.

Authors:  Jacqueline K Flynn; Paul R Gorry
Journal:  Clin Transl Immunology       Date:  2014-07-18

8.  HIV signaling through CD4 and CCR5 activates Rho family GTPases that are required for optimal infection of primary CD4+ T cells.

Authors:  Mark B Lucera; Zach Fleissner; Caroline O Tabler; Daniela M Schlatzer; Zach Troyer; John C Tilton
Journal:  Retrovirology       Date:  2017-01-24       Impact factor: 4.602

9.  Global phosphoproteomics of CCR5-tropic HIV-1 signaling reveals reprogramming of cellular protein production pathways and identifies p70-S6K1 and MK2 as HIV-responsive kinases required for optimal infection of CD4+ T cells.

Authors:  Danica D Wiredja; Caroline O Tabler; Daniela M Schlatzer; Ming Li; Mark R Chance; John C Tilton
Journal:  Retrovirology       Date:  2018-07-03       Impact factor: 4.602

10.  Central memory CD4+ T cells are preferential targets of double infection by HIV-1.

Authors:  Aiman A Haqqani; Samantha L Marek; Jagadish Kumar; Miles Davenport; Heng Wang; John C Tilton
Journal:  Virol J       Date:  2015-11-11       Impact factor: 4.099

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.